Tempus AI, Inc. (NASDAQ: TEM), headquartered in Chicago, Illinois, is a technology company revolutionizing precision medicine through artificial intelligence. By building one of the world's largest libraries of clinical and molecular data, Tempus enables physicians to make data-driven decisions in real-time, tailoring treatments to individual patients. Their platform integrates multimodal data, including genomic, clinical, and imaging information, to provide comprehensive insights across various medical fields such as oncology, cardiology, and neurology. Tempus's solutions encompass genomic sequencing, AI-driven diagnostics, and clinical trial matching, all aimed at enhancing patient outcomes. The company collaborates with academic medical centers, community hospitals, and pharmaceutical companies to drive innovation in healthcare.